OQROGet OQRO Pro
Insider trade

Repligen (RGEN)Director sold ~$466K

Anthony Hunt, Director at Repligen, sold ~$466K of Repligen shares.

~$466K
Approx. value · 3,000 sh @ $155.45
88K
Holds after · shares reported
Traded
Nov 13, 2025
Filed
Nov 15, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 28, 2025Company filing · Form 8-K · ResultsReported its results
  2. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  3. Oct 31, 2025CongressDisclosed sale of RGEN — reported range $1,001 - $15,000
  4. Nov 12, 2025Insider · 1 personInsiders: 5 sales (~$3.9M)
  5. Nov 13, 2025 · this disclosureInsiderDirector sold ~$466K of RGEN shares in the open market

What came next

  1. Nov 13, 2025Insider · 1 personInsiders: 6 sales (~$2.6M)
  2. Nov 18, 2025InsiderOfficer sold ~$331K of RGEN shares in the open market
  3. Nov 25, 2025InsiderCEO sold ~$1.2M of RGEN shares in the open market
  4. Dec 17, 2025InsiderDirector sold ~$44K of RGEN shares in the open market
  5. Jan 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On January 6, 2026, Repligen Corporation (the “Company”) announced that the Board of Directors (the “Board”) has elected Dr. Martin D. Madaus as Chair of the Board, effective March 13, 2026 (the “Effective Date”).”
  6. Feb 24, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Repligen

For Repligen, OQRO holds 10 insider filings (SEC Form 4 or Form 144), 15 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RGEN page.

Other recent filings by Anthony Hunt, Director

The full history of Anthony Hunt, Director is on the profile page.

How this filing works

Other disclosures at Repligen

Everything OQRO holds on this company is on its RGEN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data